{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:28:58Z","timestamp":1780957738303,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.jconrel.2005.12.010","type":"journal-article","created":{"date-parts":[[2006,2,8]],"date-time":"2006-02-08T18:25:05Z","timestamp":1139423105000},"page":"193-203","source":"Crossref","is-referenced-by-count":45,"title":["Selective targeting of pentoxifylline to hepatic stellate cells using a novel platinum-based linker technology"],"prefix":"10.1016","volume":"111","author":[{"given":"Teresa","family":"Gonzalo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard G.","family":"Talman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"van de Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Temming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Greupink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Beljaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Reker-Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk K.F.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grietje","family":"Molema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas","family":"Poelstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert J.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2005.12.010_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"1152","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2005.12.010_bib2","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.510290526","article-title":"Albumin modified with mannose 6-phosphate: a potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells","volume":"295","author":"Beljaars","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2005.12.010_bib3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-2001-17558","article-title":"Hepatic stellate cells as a target for the treatment of liver fibrosis","volume":"213","author":"Bataller","year":"2001","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jconrel.2005.12.010_bib4","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0016-5085(99)70413-0","article-title":"The virtuosity of hepatic stellate cells","volume":"1175","author":"Friedman","year":"1999","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.jconrel.2005.12.010_bib5","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis\u2014from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2005.12.010_bib6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1034\/j.1600-0676.2001.210504.x","article-title":"Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P28-HSA)","volume":"215","author":"Beljaars","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.jconrel.2005.12.010_bib7","doi-asserted-by":"crossref","first-page":"12743","DOI":"10.1074\/jbc.275.17.12743","article-title":"Successful targeting of albumin to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor","volume":"27517","author":"Beljaars","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2005.12.010_bib8","doi-asserted-by":"crossref","unstructured":"R. Greupink, H.I. Bakker, C. Reker-Smit, A. van Loenen-Weemaes, R.J. Kok, D.K.F. Meijer, L. Beljaars, K. Poelstra, Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell, J. Hepatol. xx (2005) x.","DOI":"10.1016\/j.jhep.2005.04.014"},{"issue":"3\u20138","key":"10.1016\/j.jconrel.2005.12.010_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0006-2952(95)02173-6","article-title":"Effect of pentoxifylline on the fibrogenic functions of cultured rat liver fat-storing cells and myofibroblasts","volume":"515","author":"Windmeier","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2005.12.010_bib10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0168-8278(99)80192-5","article-title":"Effect of pentoxifylline on early proliferation and phenotypic modulation of fibrogenic cells in two rat models of liver fibrosis and on cultured hepatic stellate cells","volume":"304","author":"Desmouli\u00e8re","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2005.12.010_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/gut.50.2.241","article-title":"Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis","volume":"502","author":"Raetsch","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2005.12.010_bib12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1006\/jmcc.1998.0910","article-title":"Pentoxifylline inhibits PDGF-induced proliferation of and TGF-beta-stimulated collagen synthesis by vascular smooth muscle cells","volume":"314","author":"Chen","year":"1999","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.jconrel.2005.12.010_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s004320100262","article-title":"Inhibition of endothelial cell proliferation and tumor-induced angiogenesis by pentoxifylline","volume":"12710","author":"Gude","year":"2001","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2005.12.010_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0162-3109(99)00186-1","article-title":"Pentoxifylline inhibits ICAM-1 expression and chemokine production induced by proinflammatory cytokines in human pulmonary epithelial cells","volume":"463","author":"Krakauer","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jconrel.2005.12.010_bib15","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/clinchem\/48.8.1352","article-title":"Use of horseradish peroxidase- and fluorescein-modified cisplatin derivatives for simultaneous labeling of nucleic acids and proteins","volume":"488","author":"van Gijlswijk","year":"2002","journal-title":"Clin. Chem."},{"issue":"7\u20137","key":"10.1016\/j.jconrel.2005.12.010_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/cbic.200200498","article-title":"Platinum(II)-based coordination compounds as nucleic acid labeling reagents: synthesis, reactivity, and applications in hybridization assays","volume":"47","author":"Heetebrij","year":"2003","journal-title":"ChemBioChem."},{"key":"10.1016\/j.jconrel.2005.12.010_bib17","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.510270238","article-title":"Purification of rat hepatic stellate cells by side scatter-activated cell sorting","volume":"27","author":"Geerts","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2005.12.010_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.119.3.493","article-title":"Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation","volume":"1193","author":"Gavrieli","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2005.12.010_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(96)00400-0","article-title":"The crucial role of spacer groups in macromolecular prodrug design","volume":"212","author":"Soyez","year":"1996","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2005.12.010_bib20","series-title":"Drug Targeting. Organ-Specific Strategies","first-page":"275","author":"Kok","year":"2001"},{"key":"10.1016\/j.jconrel.2005.12.010_bib21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/med.10038","article-title":"Platinum-based anticancer agents: innovative design strategies and biological perspectives","volume":"235","author":"Ho","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2005.12.010_bib22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2174\/1568011023353958","article-title":"Novel concepts in the development of platinum antitumor drugs","volume":"24","author":"Fuertes","year":"2002","journal-title":"Curr. Med. Chem. Anti.-Canc. Agents"},{"key":"10.1016\/j.jconrel.2005.12.010_bib23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1665-2681(19)32156-8","article-title":"A randomized study of losartan vs propranolol: effects on hepatic and systemic hemodynamics in cirrhotic patients","volume":"21","author":"Castano","year":"2003","journal-title":"Ann. Hepatol."},{"issue":"604A","key":"10.1016\/j.jconrel.2005.12.010_bib24","article-title":"Short-term treatment with losartan targeted to activated stellate cells reduces advanced liver fibrogenesis: a new strategy to treat liver fibrosis","volume":"42","author":"Gonzalo","year":"2005","journal-title":"Hepatology"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365905007236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365905007236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T15:39:38Z","timestamp":1586705978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365905007236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":24,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0168365905007236"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2005.12.010","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}